AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10590328 — intervention group
Group type: COMPARATOR
Intervention: Single HAV vaccination
Number of subjects: 150
Study 10590328 — intervention group
Group type: COMPARATOR
Intervention: Single HBV vaccination
Number of subjects: 150
Study 9289454 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium concentration in women with pregnancy threatening miscarriage
Number of subjects: 75
Study 9289454 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium concentration in women with pregnancy threatening miscarriage
Number of subjects: 75
Study 9289454 — intervention group
Group type: COMPARATOR
Intervention: Magnesium concentration in normal uterine pregnancy
Number of subjects: 75
Study 9289454 — intervention group
Group type: COMPARATOR
Intervention: Calcium concentration in normal uterine pregnancy
Number of subjects: 75
Study 2053669 — intervention group
Group type: EXPERIMENTAL
Intervention: Training about smoking cessation counseling with staff support and designated follow-up time
Number of subjects: 0
Study 2053669 — intervention group
Group type: COMPARATOR
Intervention: Training about smoking cessation counseling
Number of subjects: 0
Study 6389609 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of citric acid
Number of subjects: 0
Study 6389609 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study 31314753 — intervention group
Group type: COMPARATOR
Intervention: Weight-based dosing for diethylcarbamazine (DEC; 6 mg/kg) and ivermectin (IVM; 200 ug/kg)
Number of subjects: 26000
Study 31314753 — intervention group
Group type: EXPERIMENTAL
Intervention: New dosing pole with a 6-tablet maximum for both DEC and IVM
Number of subjects: 26000
Study 30400777 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod cream (5%)
Number of subjects: 500
Study 30400777 — intervention group
Group type: EXPERIMENTAL
Intervention: Podophyllotoxin cream (0.15%)
Number of subjects: 500
Study 30400777 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccination
Number of subjects: 500
Study 30400777 — intervention group
Group type: COMPARATOR
Intervention: Control vaccination
Number of subjects: 500
Study 26917051 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfadoxine-pyrimethamine (AS + SP)
Number of subjects: 303
Study 26917051 — intervention group
Group type: COMPARATOR
Intervention: Dihydroartemisinin-piperaquine
Number of subjects: 303
Study 24355831 — intervention group
Group type: EXPERIMENTAL
Intervention: Operating table height at nipple level (Group N)
Number of subjects: 160
Study 24355831 — intervention group
Group type: COMPARATOR
Intervention: Operating table height at umbilicus level (Group U)
Number of subjects: 160
Study 24355831 — intervention group
Group type: EXPERIMENTAL
Intervention: Operating table height at xiphoid process level (Group X)
Number of subjects: 160
Study 24355831 — intervention group
Group type: EXPERIMENTAL
Intervention: Operating table height at lowest rib margin (Group R)
Number of subjects: 160
Study 22888768 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (treatment group)
Number of subjects: 35
Study 22888768 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture (control group)
Number of subjects: 35
Study 20394651 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine (75 mg/m2/day SC for 7 days every 28 days)
Number of subjects: 325
Study 20394651 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 325
Study 20394651 — intervention group
Group type: COMPARATOR
Intervention: Conventional care regimens (CCR) including low-dose ara-C, BSC, or intensive chemotherapy
Number of subjects: 325
Study 18759641 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (mean dose = 3.4 mg)
Number of subjects: 30
Study 18759641 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (mean dose = 14.0 mg)
Number of subjects: 30
Study 18759641 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (mean dose = 611 mg)
Number of subjects: 30
Study 15856037 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin, cisplatin and infused 5FU (ECF)
Number of subjects: 54
Study 15856037 — intervention group
Group type: EXPERIMENTAL
Intervention: 5FU, etoposide and leucovorin (FELV)
Number of subjects: 54
Study 12209270 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NPPV)
Number of subjects: 48
Study 12209270 — intervention group
Group type: COMPARATOR
Intervention: Invasive mechanical ventilation
Number of subjects: 48
Study 10478770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability assessment
Number of subjects: 18
Study 10478770 — intervention group
Group type: EXPERIMENTAL
Intervention: Interexaminer reliability assessment
Number of subjects: 18
Study 10478770 — intervention group
Group type: EXPERIMENTAL
Intervention: Second examination
Number of subjects: 18
Study 8941061 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-pellet system containing 174 mg NET
Number of subjects: 39
Study 8941061 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-pellet system containing 266.5 mg NET
Number of subjects: 39
Study 8941061 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 39
Study 1746792 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmetazole
Number of subjects: 138
Study 1746792 — intervention group
Group type: COMPARATOR
Intervention: Cefoperazone
Number of subjects: 138
Study 1746792 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 138
Study 1746792 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 138
Study 1746792 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 138
Study 1746792 — intervention group
Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 138
Study 2995463 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antibiotic ointment (bacitracin, polysporin, neomycin) applied thrice daily
Number of subjects: 59
Study 2995463 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 59
Study 2995463 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antibiotic ointment
Number of subjects: 59
Study 30660559 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic resistance training and eccentric overload (ISO/ECC)
Number of subjects: 22
Study 30660559 — intervention group
Group type: COMPARATOR
Intervention: Traditional resistance training (TRAD)
Number of subjects: 22
Study 29703470 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg BID
Number of subjects: 574
Study 29703470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 574
Study 27893676 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel (175mg/m2) alone
Number of subjects: 24
Study 27893676 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of paclitaxel and Avastin (5 mg/kg)
Number of subjects: 24
Study 25300112 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin-mineral complex (VMC) with additional intake of vitamins C and E (100-120% RDA), beta-carotene (40% RDA), nicotinamide (38% RDA), pantothenic acid and biotin (60% RDA), vitamins B12, B2 and folic acid (75-83% RDA), vitamins B1 and B6 (160-300% RDA), zinc (100% RDA), chromium (400% RDA), magnesium (17.7% RDA), and potassium (9.4% RDA)
Number of subjects: 120
Study 25300112 — intervention group
Group type: COMPARATOR
Intervention: Low-calorie diet (1600 kcal/day)
Number of subjects: 120
Study 22755281 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation with distraction
Number of subjects: 60
Study 22755281 — intervention group
Group type: COMPARATOR
Intervention: Plaster of Paris cast
Number of subjects: 60
Study 20944078 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative management
Number of subjects: 14302
Study 20944078 — intervention group
Group type: COMPARATOR
Intervention: Radical prostatectomy
Number of subjects: 14302
Study 21328517 — intervention group
Group type: EXPERIMENTAL
Intervention: Balaglitazone 10 mg
Number of subjects: 409
Study 21328517 — intervention group
Group type: EXPERIMENTAL
Intervention: Balaglitazone 20 mg
Number of subjects: 409
Study 21328517 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg
Number of subjects: 409
Study 15766816 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300-mg load followed by 75 mg/day) plus aspirin
Number of subjects: 12562
Study 15766816 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 12562
Study 12779109 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (10 mg/kg)
Number of subjects: 22
Study 12779109 — intervention group
Group type: COMPARATOR
Intervention: Ketamine (10 mg/kg) + Promethazine (1.1 mg/kg)
Number of subjects: 22
Study 9866432 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocarditis prophylaxis
Number of subjects: 0
Study 9866432 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative anticoagulation in patients with mechanical heart valves
Number of subjects: 0
Study 9866432 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose control in diabetic patients undergoing surgery
Number of subjects: 0
Study 9866432 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of beta-blockers to prevent postoperative cardiac complications
Number of subjects: 0
Study 8010474 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac infusion
Number of subjects: 207
Study 8010474 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac bolus
Number of subjects: 207
Study 8010474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 8010474 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac infusion and bolus
Number of subjects: 207
Study 2688532 — intervention group
Group type: EXPERIMENTAL
Intervention: iopromide 370
Number of subjects: 20
Study 2688532 — intervention group
Group type: COMPARATOR
Intervention: ioxaglate 320
Number of subjects: 20
Study 31944878 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) with fixed appliance
Number of subjects: 89
Study 31944878 — intervention group
Group type: COMPARATOR
Intervention: Control group (fixed appliance only)
Number of subjects: 89
Study 29779564 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5-hour alertness management training followed by a two-month consultation period and motivational self-evaluation tasks
Number of subjects: 53
Study 29779564 — intervention group
Group type: COMPARATOR
Intervention: Usual statutory occupational health care services (Control)
Number of subjects: 53
Study 28157112 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-mode stimulation (10Hz rTMS at 90% resting motor threshold, 1,000 pulses for 20 minutes + cathodal tDCS at 2mA)
Number of subjects: 30
Study 28157112 — intervention group
Group type: COMPARATOR
Intervention: Single stimulation (10Hz rTMS without tDCS)
Number of subjects: 30
Study 28316664 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback therapy (20 sessions of 40 minutes each, 3 sessions per week)
Number of subjects: 8
Study 28316664 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 8
Study 23966698 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS) with PPC preceding M1 TMS by 5 ms
Number of subjects: 0
Study 23966698 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS) with PPC following M1 TMS by 5 ms
Number of subjects: 0
Study 23966698 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotating the stimulating coil in M1 during the PAS protocol
Number of subjects: 0
Study 20371017 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgical reconstruction without reinforcement
Number of subjects: 51
Study 20371017 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini‐invasive procedure
Number of subjects: 51
Study 20371017 — intervention group
Group type: COMPARATOR
Intervention: Control Group (healthy subjects)
Number of subjects: 51
Study 18925524 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH enoxaparin sodium (80 IU/kg) administered 10 minutes after the beginning of HD
Number of subjects: 18
Study 18925524 — intervention group
Group type: COMPARATOR
Intervention: No LMWH administration during the first 20 minutes of HD
Number of subjects: 18
Study 16612068 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 4 weeks
Number of subjects: 48
Study 12553388 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid yoke with surface area of 3 cm2 at forces of 10 N, 20 N, 30 N, and 40 N
Number of subjects: 50
Study 12553388 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid yoke with surface area of 10 cm2 at forces of 10 N, 20 N, 30 N, and 40 N
Number of subjects: 50
Study 10778884 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg DHEA administered orally at 0700 hours
Number of subjects: 0
Study 10778884 — intervention group
Group type: COMPARATOR
Intervention: Placebo (old-PL)
Number of subjects: 0
Study 8793448 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nedocromil sodium
Number of subjects: 201
Study 8793448 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2 mg nedocromil sodium and 100 micrograms salbutamol
Number of subjects: 201
Study 1333423 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/day itraconazole for 15 days
Number of subjects: 40
Study 1333423 — intervention group
Group type: COMPARATOR
Intervention: 500 mg/day griseofulvin for 15 days
Number of subjects: 40
Study 1333423 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study 1333423 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/day itraconazole
Number of subjects: 40
Study 1333423 — intervention group
Group type: COMPARATOR
Intervention: 500 mg/day griseofulvin
Number of subjects: 40
Study 1333423 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 40
Study 6609243 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month exercise-based Cardiac Rehabilitation Program
Number of subjects: 48
Study 6609243 — intervention group
Group type: COMPARATOR
Intervention: Routine-care condition
Number of subjects: 48
Study 30991399 — intervention group
Group type: EXPERIMENTAL
Intervention: OZOILE cream (ozonides with vitamin E acetate)
Number of subjects: 30
Study 30991399 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% mometasone furoate (topical corticosteroid)
Number of subjects: 30
Study 30991399 — intervention group
Group type: COMPARATOR
Intervention: Untreated foreskin (control group)
Number of subjects: 30
Study 29156456 — intervention group
Group type: EXPERIMENTAL
Intervention: AUC0-72
Number of subjects: 15
Study 29156456 — intervention group
Group type: EXPERIMENTAL
Intervention: AUC0-144
Number of subjects: 15
Study 26819292 — intervention group
Group type: EXPERIMENTAL
Intervention: Freestyle
Number of subjects: 56
Study 26819292 — intervention group
Group type: EXPERIMENTAL
Intervention: Magna Ease
Number of subjects: 56
Study 26819292 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifecta
Number of subjects: 56
Study 25278098 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - Participants asked to conceal the presence of prohibited items in the backpack.
Number of subjects: 0
Study 25278098 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - Participants not asked to conceal items.
Number of subjects: 0
Study 22531061 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused-image ultrasonography with vertical vectoring of 15 treatment lines at dual tissue depths
Number of subjects: 0
Study 22531061 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused-image ultrasonography with more treatment lines and higher joule energy at dual depths
Number of subjects: 0
Study 22531061 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused-image ultrasonography
Number of subjects: 0
Study 20171776 — intervention group
Group type: EXPERIMENTAL
Intervention: IMSI
Number of subjects: 30
Study 20171776 — intervention group
Group type: COMPARATOR
Intervention: ICSI
Number of subjects: 30
Study 18600434 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g PEG 400
Number of subjects: 12
Study 18600434 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 g PEG 400
Number of subjects: 12
Study 18600434 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g PEG 400
Number of subjects: 12
Study 18600434 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 g PEG 400
Number of subjects: 12
Study 18600434 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g PEG 400
Number of subjects: 12
Study 18600434 — intervention group
Group type: COMPARATOR
Intervention: 0 g PEG 400 (control)
Number of subjects: 12
Study 16084919 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot bathing at 40 degrees C for 1 hour
Number of subjects: 6
Study 16084919 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot bathing at 41 degrees C for 1 hour
Number of subjects: 6
Study 12062222 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg)
Number of subjects: 10
Study 9864074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for up to 12 weeks (short-term therapy)
Number of subjects: 89
Study 9864074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 52 weeks (long-term therapy)
Number of subjects: 89
Study 9864074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine for 38 weeks, then placebo for 14 weeks (long-term therapy)
Number of subjects: 89
Study 9864074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine for 14 weeks, then placebo for 38 weeks (long-term therapy)
Number of subjects: 89
Study 9864074 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 52 weeks (long-term therapy)
Number of subjects: 89
Study 9864074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine for 52 weeks (long-term therapy)
Number of subjects: 89
Study 7634517 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillar fossa obliteration using 2/0 Polydioxanone (PDS II) suture
Number of subjects: 50
Study 7634517 — intervention group
Group type: COMPARATOR
Intervention: Control side (no intervention)
Number of subjects: 50
Study 2094589 — intervention group
Group type: COMPARATOR
Intervention: Peptide Plasmodium falciparum sporozoite vaccine conjugated to tetanus toxoid ((NANP)3‐TT) plus placebo (group 1)
Number of subjects: 37
Study 2094589 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon‐alpha (IFN‐alpha) (group 2)
Number of subjects: 37
Study 359628 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine 120 mg
Number of subjects: 35
Study 359628 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine 60 mg
Number of subjects: 35
Study 359628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 31746327 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 400 IU/day
Number of subjects: 373
Study 31746327 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU/day
Number of subjects: 373
Study 31746327 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 10,000 IU/day
Number of subjects: 373
Study 31746327 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 373
Study 29558233 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron isomaltoside (1200 mg)
Number of subjects: 85
Study 29558233 — intervention group
Group type: COMPARATOR
Intervention: Current treatment practice with oral iron
Number of subjects: 85
Study 28422820 — intervention group
Group type: EXPERIMENTAL
Intervention: VivaSight SL endotracheal tube (ETView group)
Number of subjects: 67
Study 28422820 — intervention group
Group type: COMPARATOR
Intervention: Standard direct laryngoscopy (MAC group)
Number of subjects: 67
Study 25573027 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) and conventional swallowing therapy
Number of subjects: 20
Study 25573027 — intervention group
Group type: COMPARATOR
Intervention: Sham electrical stimulation (SES) and conventional swallowing therapy
Number of subjects: 20
Study 25573027 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 20
Study 24516695 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil injection 15 minutes after endoscopy
Number of subjects: 200
Study 24516695 — intervention group
Group type: COMPARATOR
Intervention: Flumazenil injection immediately after endoscopy
Number of subjects: 200
Study 23071074 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) 100% oxygen at 1.5atm
Number of subjects: 49
Study 23071074 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric air (HBA) 14% oxygen at 1.5atm
Number of subjects: 49
Study 23071074 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO)
Number of subjects: 49
Study 23071074 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric air (HBA)
Number of subjects: 49
Study 19753607 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichosanthes kirilowii (TK) seed kernels containing 3 g of punicic acid (PA) per day for 28 days
Number of subjects: 30
Study 19753607 — intervention group
Group type: COMPARATOR
Intervention: Sunflower seed kernels (control group)
Number of subjects: 30
Study 18085913 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 187
Study 18085913 — intervention group
Group type: COMPARATOR
Intervention: Diversified Placement Approach (DPA)
Number of subjects: 187
Study 15131030 — intervention group
Group type: EXPERIMENTAL
Intervention: TA-CIN (HPV-16 L2/E6/E7 protein)
Number of subjects: 29
Study 12207145 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride 200-600 mg/day
Number of subjects: 18
Study 12207145 — intervention group
Group type: COMPARATOR
Intervention: Flupenthixol 5-15 mg/day
Number of subjects: 18
Study 9062774 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol treatment
Number of subjects: 0
Study 7505970 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride, a 5-alpha reductase inhibitor, dosage and duration not specified.
Number of subjects: 0
Study 7505970 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0
Study 3826899 — intervention group
Group type: COMPARATOR
Intervention: Metered-dose inhaler (MDI)
Number of subjects: 12
Study 3826899 — intervention group
Group type: EXPERIMENTAL
Intervention: Metered-dose inhaler with holding chamber (MDI-HC)
Number of subjects: 12
Study 30984999 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic LOR syringe - Epimatic®
Number of subjects: 170